(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Computer Task Group, Inc. (NASDAQ: CTG)'s sale to Cegeka Groep NV for $10.50 per share in cash. If you are a Computer Task shareholder, click here to learn more about your rights and options .
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE)'s sale to Harmony Biosciences Holdings, Inc. Under the terms of the agreement, Harmony would acquire all outstanding shares of Zynerba for $1.1059 per share in cash, pone non-tradeable contingent value right per share, representing the right to receive potential additional payments of up to $140 million in the aggregate, subject to the achievement of certain clinical, regulatory and sales milestones. If you are a Zynerba shareholder, click here to learn more about your rights and options .
Kaleyra, Inc. (NYSE: KLR)'s sale to Tata Communications for $7.25 per share. If you are a Kaleyra shareholder, click here to learn more about your rights and options .
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email or .
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
Tags Class Action
MENAFN31082023004107003653ID1106992336
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.